1. Vaginal Cancer Global Clinical Trials Review, H2, 2012
Report Details:
Published:November 2012
No. of Pages: 81
Price: Single User License – US$2500
Vaginal Cancer Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2012"
provides data on the Vaginal Cancer clinical trial scenario. This report provides elemental
information and data relating to the clinical trials on Vaginal Cancer. It includes an overview of the
trial numbers and their recruitment status as per the site of trial conduction across the globe. The
databook offers a preliminary coverage of disease clinical trials by their phase, trial status,
prominence of the sponsors and also provides briefing pertaining to the number of trials for the key
drugs for treating Vaginal Cancer. This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by GlobalData''s
team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America,
Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along
with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and
sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location,
sponsor type and many more

2. - Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Get your copy of this report @
http://www.reportsnreports.com/reports/210598-vaginal-cancer-global-clinical-trials-review-h2-2012.html
Major points covered in Table of Contents of this report include
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vaginal Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Nations 12
Clinical Trials in G7 Nations by Trial Status 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Unaccomplished Trials of Vaginal Cancer 17
Subjects Recruited Over a Period of Time 18
Prominent Sponsors 19
Prominent Drug Comparison 21
Clinical Trial Profiles 22
Clinical Trial Overview of Top Companies 22
Merck & Co., Inc. 22
Clinical Trial Overview of Merck & Co., Inc. 22
Clinical Trial Overview of Top Universities / Institutes / Hospitals 23
Case Comprehensive Cancer Center 23
Clinical Trial Overview of Case Comprehensive Cancer Center 23
Memorial Sloan Kettering Cancer Center 24
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 24
The University of Texas M. D. Anderson Cancer Center 25
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 25
Dana-Farber Cancer Institute 26
Clinical Trial Overview of Dana-Farber Cancer Institute 26
Masonic Cancer Center 27
Clinical Trial Overview of Masonic Cancer Center 27
Centre Oscar Lambret 28

3. Clinical Trial Overview of Centre Oscar Lambret 28
U.S. Army Medical Research Institute of Infectious Diseases 29
Clinical Trial Overview of U.S. Army Medical Research Institute of Infectious Diseases 29
Absenger Cancer Education Foundation 30
Clinical Trial Overview of Absenger Cancer Education Foundation 30
University of Maryland Greenebaum Cancer Center 31
Clinical Trial Overview of University of Maryland Greenebaum Cancer Center 31
NYU Cancer Institute 32
Clinical Trial Overview of NYU Cancer Institute 32
Maastricht Radiation Oncology 33
Clinical Trial Overview of Maastricht Radiation Oncology 33
Brigham and Women''s Hospital 34
Clinical Trial Overview of Brigham and Women''s Hospital 34
Fred Hutchinson Cancer Research Center 35
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 35
The University of Chicago 36
Clinical Trial Overview of The University of Chicago 36
University of Toronto 37
Clinical Trial Overview of University of Toronto 37
Northwestern University 38
Clinical Trial Overview of Northwestern University 38
Roswell Park Cancer Institute 39
Clinical Trial Overview of Roswell Park Cancer Institute 39
Leiden University Medical Center 40
Clinical Trial Overview of Leiden University Medical Center 40
University Health Network 41
Clinical Trial Overview of University Health Network 41
Five Key Clinical Profiles 42
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 81
List of Tables
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Vaginal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

4. Vaginal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 10
Vaginal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 11
Vaginal Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 12
Vaginal Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 14
Vaginal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 15
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16
Vaginal Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 17
Vaginal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-
2011 18
Vaginal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 20
Vaginal Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 21
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc.,
2012* 22
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case
Comprehensive Cancer Center, 2012* 23
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan
Kettering Cancer Center, 2012* 24
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of
Texas M. D. Anderson Cancer Center, 2012* 25
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer
Institute, 2012* 26
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer
Center, 2012* 27
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Oscar
Lambret, 2012* 28
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical
Research Institute of Infectious Diseases, 2012* 29
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Absenger Cancer
Education Foundation, 2012* 30
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of
Maryland Greenebaum Cancer Center, 2012* 31
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NYU Cancer
Institute, 2012* 32
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht Radiation
Oncology, 2012* 33
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and
Women''s Hospital, 2012* 34
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson
Cancer Research Center, 2012* 35
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of
Chicago, 2012* 36

5. Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto,
2012* 37
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern
University, 2012* 38
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer
Institute, 2012* 39
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University
Medical Center, 2012* 40
Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health
Network, 2012* 41
List of Figures
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Vaginal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Vaginal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 10
Vaginal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 11
Vaginal Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 12
Vaginal Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 14
Vaginal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 15
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16
Vaginal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-
2011 18
Vaginal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 19
Vaginal Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 21
GlobalData Methodology 79
Contact: sales@reportsandreports.com for more information.